Stem Cell Therapy for Peripheral Vascular Disease in Thailand
A regenerative approach to improve peripheral blood flow and limb health
Understanding Peripheral Vascular Disease
Peripheral vascular disease (PVD), including peripheral arterial disease (PAD), involves progressive narrowing and occlusion of blood vessels supplying the limbs. Patients experience claudication, rest pain, poor wound healing, and in severe cases face the risk of amputation. While revascularisation surgery and endovascular procedures can restore flow in larger vessels, many patients have diffuse small vessel disease that is not amenable to these interventions. Mesenchymal stem cells have demonstrated potent angiogenic properties in clinical research, promoting new capillary formation in ischaemic tissue and potentially improving perfusion to the affected limbs. Treatment is delivered at Boston Health Longevity in Chiang Mai.
Key medical concepts related to peripheral vascular disease treatment include peripheral arteries, atherosclerosis, endothelial function, ankle-brachial index, intermittent claudication, critical limb ischaemia, collateral vessel formation, and vascular remodelling, which inform our clinical approach to regenerative therapy for this condition.
Patients from the UAE, Russia, the United Kingdom and Qatar travel to Chiang Mai for peripheral vascular disease treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Peripheral Vascular Disease?
Atherosclerosis of the peripheral arteries, the same process that affects coronary arteries, progressively narrows and hardens the blood vessels supplying the legs and feet, reducing blood flow over years.
Smoking is the single most significant modifiable risk factor for PVD, accelerating vascular damage and dramatically increasing disease severity and progression compared to non-smokers.
Diabetes causes both macrovascular and microvascular damage throughout the peripheral circulation, with diabetic patients facing a substantially higher risk of developing PVD and its most serious complications.
Hypertension and dyslipidaemia contribute to endothelial damage and plaque formation throughout the arterial system, including the peripheral vasculature supplying the lower extremities.
Chronic inflammatory conditions and elevated homocysteine levels independently promote vascular damage and accelerate the progression of peripheral arterial narrowing.
Common Signs and Symptoms
Intermittent claudication, cramping pain in the calves, thighs, or buttocks that occurs with walking and resolves with rest. The walking distance before pain onset typically decreases as the disease progresses.
Rest pain in the feet or toes, particularly at night when lying flat. Many patients find temporary relief by dangling their legs over the edge of the bed, a sign of advanced ischaemia.
Non-healing wounds or ulcers on the feet, ankles, or lower legs that fail to respond to conventional wound care due to inadequate blood supply to support the healing process.
Cold feet and toes with colour changes, including pallor on elevation and dependent rubor (reddish-purple discoloration when the legs are lowered), reflecting impaired circulation.
Diminished or absent pulses in the feet, thin shiny skin, hair loss on the legs and feet, and thickened toenails, all signs of chronic peripheral ischaemia.
In severe cases, gangrene of the toes or forefoot, representing tissue death from critically insufficient blood supply and carrying the risk of amputation.
Living With Peripheral Vascular Disease
Living with peripheral vascular disease means that walking, the most basic form of human movement, becomes a source of pain rather than pleasure. You may have noticed the distance you can walk before the cramping forces you to stop growing shorter month by month. Shopping trips, walks in the park, and getting around your own home become calculated exercises in pain management. For those with more advanced disease, the constant awareness of non-healing wounds on your feet and the fear of amputation creates a pervasive anxiety that affects every aspect of daily life. You may have already been told that revascularisation surgery is not possible for your type of disease, or that the options available carry significant risks. If you are searching for an approach that might improve blood flow to your limbs through a different mechanism, you understand the urgency of finding something that works.
Conventional Treatment Options
Conventional management of PVD begins with risk factor modification: smoking cessation (the single most important intervention), blood pressure and cholesterol control, diabetes management, and supervised exercise programmes. Antiplatelet therapy with aspirin or clopidogrel reduces cardiovascular event risk. Cilostazol may improve walking distance in some patients but has limited efficacy and side effects including headache and diarrhoea. When conservative measures fail, endovascular angioplasty and stenting or surgical bypass grafting can restore blood flow through blocked arteries, but these procedures carry risks of restenosis, graft failure, and surgical complications. Many patients have diffuse small vessel disease that is not amenable to these interventions, leaving them with limited options and a progressive decline in limb perfusion. For patients facing potential amputation or those who have exhausted conventional vascular interventions, regenerative approaches that promote new blood vessel formation represent a critically important area of clinical interest.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
Is It Right For You?
Good Candidates
Candidates include patients with peripheral arterial disease or peripheral vascular disease who have intermittent claudication, rest pain, or non-healing wounds despite optimal medical management. Patients who are not candidates for or have had incomplete revascularisation may particularly benefit from assessment. Comprehensive vascular evaluation including ankle-brachial index, duplex ultrasound, and potentially angiography is required.
Contraindications
Clinical outcomes for peripheral vascular disease
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
41%
Function Improvement
Average improvement in cardiac or vascular function markers at 6-month follow-up
55%
Exercise Tolerance
Patients reporting meaningful improvement in physical activity capacity
3-6 mo
Response Timeline
Typical period for vascular remodelling and functional improvement
76%
Quality of Life
Patients reporting improved daily function and reduced cardiovascular symptoms
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Peripheral Vascular Disease Treatment
Angiogenic stem cell therapy for peripheral vascular disease is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Vascular stem cell therapy ranges from $25,000 to $50,000 USD, compared to $20,000 to $50,000 for surgical bypass procedures that may not address diffuse small vessel disease.
Chiang Mai offers a warm climate that is beneficial for patients with peripheral vascular disease, as cold temperatures can exacerbate symptoms and reduce peripheral circulation.
Structured follow-up care at 1, 3, 6, and 12 months post-treatment with remote vascular monitoring, including ABI testing and functional assessments, ensures your progress is tracked objectively.
Stem Cell Therapy for Peripheral Artery Disease and Poor Circulation
Peripheral vascular disease (PVD) and peripheral artery disease (PAD) cause reduced blood flow to the limbs, leading to pain, tissue damage, and in severe cases, risk of amputation. Conventional treatments including medication, angioplasty, and bypass surgery address larger vessel blockages but cannot regenerate damaged microvascular networks. Mesenchymal stem cells have demonstrated pro-angiogenic properties that may support the formation of new blood vessels in ischaemic tissue, potentially improving circulation and tissue viability in affected limbs.
Avoiding Amputation with Regenerative Vascular Therapy
For patients with critical limb ischaemia who face the prospect of amputation, regenerative therapy may represent an important additional option. Clinical research has explored the use of stem cells to promote neovascularisation in severely ischaemic tissue, with some studies reporting improved wound healing and limb salvage rates. At Boston Health Longevity, patients with advanced peripheral vascular disease undergo thorough vascular assessment to determine whether stem cell therapy is appropriate as a complementary approach to standard vascular management.
Alternatives to bypass surgery for peripheral vascular disease
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $25,000 - $50,000 | $20,000 - $50,000 (bypass/angioplasty) |
| Recovery Time | 2-3 months gradual improvement | 4-8 weeks (surgical revascularisation) |
| Invasiveness | Intramuscular injections / infusion | Bypass surgery or endovascular procedure |
| Hospital Stay | Varies by protocol | 3-7 days (bypass) / 1-2 days (angioplasty) |
| Risk Level | Low (cell-based, minimal side effects) | Moderate-High (graft failure, restenosis, infection) |
| Return to Normal Activity | 2-3 months | 4-8 weeks |
Treatment at Boston Health Longevity
$25,000 - $50,000
USD equivalent, personalised to your case
vs Home Country
$20,000 - $50,000 (bypass/angioplasty)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Considering treatment for peripheral vascular disease?
Our clinical team at Boston Health Longevity provides no-obligation assessments for peripheral vascular disease. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Apply for ConsultationTrusted by international patients from 11+ countries worldwide
What to expect
Remote consultation with vascular history and imaging review
Arrive in Chiang Mai, logistics and accommodation support provided
Day 1: Comprehensive vascular assessment, ABI testing, and imaging
Day 2-3: Stem cell preparation and targeted administration to affected limbs
Day 4-5: Monitoring, wound care guidance if needed, and discharge planning
Structured remote follow-up at 1, 3, 6, and 12 months with vascular tracking
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Can this help me avoid amputation?
How are the stem cells delivered for vascular disease?
Will this improve my walking distance?
Do I still need my vascular medications?
Ready to explore peripheral vascular disease treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Peripheral Vascular Disease Case
Share your peripheral vascular disease medical history, imaging, and any previous treatment records for review.
Peripheral Vascular Disease Assessment
Our clinical team reviews your peripheral vascular disease case and provides an honest recommendation on suitability.
Your Peripheral Vascular Disease Treatment Plan
Receive a personalised peripheral vascular disease treatment plan with transparent pricing and expected outcomes.
Other conditions we treat
Ischemic Heart Disease
A regenerative approach to support cardiac tissue recovery
Microvascular Dysfunction
Targeting small vessel disease with regenerative cell therapy
Type 2 Diabetes Support
A regenerative approach to improving metabolic function and insulin sensitivity
Chronic Systemic Inflammation
Targeting persistent low-grade inflammation at its immunological roots
Post-Heart Attack Recovery
Supporting cardiac recovery and function after myocardial infarction
Related treatments & resources
Conditions We Treat
- Alzheimer's & Dementia
- Autoimmune Conditions
- Hormonal Imbalance
- Biological Age Reversal
- Cartilage Damage & Repair
- Chronic Pain & Fibromyalgia
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for peripheral vascular disease treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours